Clathrin-Mediated Entry of Type III GCRV
2026-08-31
Wang et al. used inhibitor profiling, transmission electron microscopy, and RT-qPCR to show that genotype III grass carp reovirus GCRV104 enters CIK cells through a dynamin-dependent, acidic clathrin-mediated endocytic pathway. The study also clarifies that nocodazole-sensitive microtubule function is not required under the tested conditions, making the compound a useful mechanistic comparator rather than an antiviral lead in this model.
miR-18a/ALOXE3 Axis in Glioblastoma
2026-08-30
The reference study identifies a miR-18a/ALOXE3 regulatory axis that links lipid metabolism with ferroptosis resistance and glioblastoma cell migration. Its integrated genetic, biochemical, cellular, and orthotopic mouse experiments provide a mechanistic framework for interpreting ALOXE3 as a potential tumor-suppressive factor in GBM rather than merely a correlational marker.
AL-8810: Prostaglandin F2α Antagonist Workflows
2026-08-29
Use AL-8810 to separate PGF2α/FP receptor signaling from downstream vascular, endometrial, and smooth-muscle effects. This workflow combines competitive antagonism, time-resolved pathway assays, and practical controls for reproducible mechanism-of-action studies.
PGF2α/PTGFR Controls Endometrial Breakdown in Mice
2026-08-29
This 2024 study identifies PGF2α signaling through PTGFR, also known as the FP receptor, as a functional driver of endometrial breakdown and vascular remodeling in a mouse menstrual-like model. By combining receptor inhibition with HIF-1α perturbation and promoter-binding analysis, the work connects hypoxia-responsive transcriptional control to prostaglandin-mediated changes in vascular permeability and tissue shedding.
I-BET-762: From BET Biology to Translational Strategy
2026-08-28
I-BET-762 offers translational researchers a selective BET inhibitor framework for connecting LPS-driven inflammatory transcription with BRD4-dependent ferroptosis sensitivity. This article interprets the evidence, defines decision-ready workflows, and outlines how to move from mechanistic signal to robust preclinical strategy.
V5 Epitope Tag Peptide: From Tag to Kinetic Probe
2026-08-28
The V5 Epitope Tag Peptide is examined as more than a detection reagent: it is a sequence-defined control for antibody-based assay design. Learn how antigen presentation, antibody dissociation, and readout selection shape Western blot, immunoprecipitation, localization, and advanced imaging workflows.
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-08-27
The reference review explains why dabigatran etexilate represented a major shift from parenteral anticoagulants and vitamin K antagonists toward oral, predictable direct thrombin inhibition. Its pharmacokinetic independence from CYP450 metabolism, combined with evidence across venous thromboembolism and nonvalvular atrial fibrillation, supports a more targeted approach to anticoagulant selection while keeping renal function and bleeding risk central.
Viral RIPK3 Degradation Drives Inflammation
2026-08-27
Liu and colleagues identified a viral inducer of RIPK3 degradation, or vIRD, that recruits host SCF machinery to ubiquitinate and eliminate the necroptosis adaptor during orthopoxvirus infection. Reverse-genetic and mouse studies showed that vIRD is not simply an intracellular death suppressor: its activity shapes viral replication, inflammation, and disease severity through RIPK3–MLKL-dependent mechanisms.
O-propargyl-puromycin (OPP) for Protein Synthesis
2026-08-26
O-propargyl-puromycin (OPP) converts transient translation into a measurable chemical signal, supporting protein synthesis measurement in cells from bulk cultures to sorted immune populations. This workflow guide applies OPP to the Pcbp1–mitochondrial integrity question in B cells while emphasizing controls, normalization, and troubleshooting.
Boc-D-FMK: From Apoptosis Control to Translation
2026-08-26
A mechanistic and strategic guide to using Boc-D-FMK as a pan-caspase inhibitor in apoptosis research, inflammation research, renal endothelial inflammation models, and hepatocyte apoptosis models, with a framework for translating pathway-level observations into stronger disease hypotheses.
PGF2α/PTGFR Controls Endometrial Breakdown
2026-08-25
A 2024 mouse menstrual-like model study identifies PGF2α signaling through PTGFR as a regulator of endometrial shedding and vascular remodeling downstream of progesterone withdrawal. Pharmacological inhibition, molecular profiling, histology, and chromatin assays connect PTGFR activity with HIF-1α, VEGF-A, angiostatin, and vascular permeability, offering a mechanistic framework for studying menstrual-like tissue breakdown.
LRPPRC–Dasatinib Dual-Genome OXPHOS Synergy
2026-08-25
The reference study identifies Dasatinib as a synergistic partner for LRPPRC inhibition and explains the effect through complementary disruption of nuclear- and mitochondrial genome-encoded OXPHOS programs. Its screening and validation strategy provides a framework for studying metabolism-directed combination therapy while highlighting the need for careful mechanistic and translational validation.
AT-406 (SM-406): Applied Apoptosis Workflows
2026-08-24
AT-406 (SM-406) links multi-IAP antagonism to practical apoptosis assays, combination studies, and translational oncology models. This workflow-focused guide covers dosing, mechanistic readouts, carboplatin sensitization, xenograft context, and troubleshooting for reproducible cancer research.
Bone Transport Links TGF-β1 to Diabetic Foot Repair
2026-08-23
This rat study identifies TGF-β1/TGFBR1 activation as a mechanistic bridge between bone transport, angiogenesis, immune regulation, and diabetic foot ulcer repair. Its combined surgical, proteomic, molecular, and histological design supports pathway involvement while also highlighting the need for better-defined inhibitors and clinical validation.
HotStart 2X Green qPCR Master Mix for COPD
2026-08-22
Build sensitive, reproducible SYBR Green assays for PM2.5-related inflammation, oxidative stress, and airway remodeling research. This workflow shows how hot-start specificity, melt-curve control, and disciplined normalization can support real-time PCR gene expression analysis and RNA-seq validation.
464 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page